CONICET discovers a combination to treat cancer and eye diseases
A study presented by scientists from the CONICET shows the antitumor effect of the combination of two drugs, Bevacizumab and Suramin, which is currently used to combat oncologic and ophthalmic diseases.
Dr. Juan Eduardo Gallo, a clinical researcher at CONICET, said that “it is a scientific backing.”
Read the full story at the Health section of Momento 24
Related News
Recent Comments